Your institution may have access to this item. Find your institution then sign in to continue.
Title
Clinical trial: prophylactic intravenous alanyl-glutamine reduces the severity of gastrointestinal toxicity induced by chemotherapy--a randomized crossover study.
Authors
Li, Y; Ping, X; Yu, B; Liu, F; Ni, X; Li, J
Abstract
Glutamine has been shown in numerous studies to reduce intestinal permeability which can be increased by chemotherapy. However, there have been few reports that conduct on its clinical effect on gastrointestinal toxicity.